Clinical Trial Update: New IR Biomarkers (Myokines) in Colombian People

View source ↗

Summary

Completed clinical trial from the University of Los Andes in Colombia evaluating new insulin resistance biomarkers (myokines) in Colombian participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Type 2 Diabetes Mellitus

Snippet

Sponsor: University of Los Andes, Columbia | Conditions: Insulin Resistance, Diabetes Mellitus, Type 2 | Status: COMPLETED